The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review
Open accessAbstract
Objectives: to determine the effect of drugs with anti-cholinergic properties on relevant health outcomes. Design: electronic published and unpublished literature/trial registries were systematically reviewed. Studies evaluating medications with anti-cholinergic activity on cognitive function, delirium, physical function or mortality were eligible. Results: forty-six studies including 60,944 participants were included. Seventy-seven percent of included studies evaluating cognitive function (n = 33) reported a significant decline in cognitive ability with increasing anti-cholinergic load (P < 0.05). Four of five included studies reported no association with delirium and increasing anti-cholinergic drug load (P > 0.05). Five of the eight included studies reported a decline in physical function in users of anti-cholinergics (P < 0.05). Three of nine studies evaluating mortality reported that the use of drugs with anti-cholinergic properties was associated with a trend towards increased mortality, but this was not statistically significant. The methodological quality of the evidence-base ranged from poor to very good. Conclusion: medicines with anti-cholinergic properties have a significant adverse effect on cognitive and physical function, but limited evidence exists for delirium or mortality outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
(2014) · Medical Entomology and Zoology · Cited by 17,633
Assessing Risk of Bias in Included Studies
Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch8 · Cited by 3,396 · cited 1×
“The Cochrane Risk of Bias tool [16] was used to assess methodological quality for all RCTs.”
MethodIncidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting
Gurwitz, J. H., Field, T. S., Harrold, L. R., Rothschild, J., Debellis, K., Seger, A. C., Cadoret, C., Fish, L. S., Garber, L., Kelleher, M., et al. (2003) · JAMA · doi:10.1001/jama.289.9.1107 · Cited by 1,676
Pandharipande, P., Shintani, A., Peterson, J., Pun, B. T., Wilkinson, G. R., Dittus, R. S., Bernard, G. R., & Ely, E. W. (2006) · Anesthesiology · doi:10.1097/00000542-200601000-00005 · Cited by 1,238
Fox, C., Richardson, K., Maidment, I. D., Savva, G. M., Matthews, F. E., Smithard, D., Coulton, S., Katona, C., Boustani, M. A., & Brayne, C. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03491.x · Cited by 655
Self-citationAncelin, M. L., Artero, S., Portet, F., Dupuy, A.-M., Touchon, J., & Ritchie, K. (2006) · BMJ · doi:10.1136/bmj.38740.439664.de · Cited by 589
The cognitive impact of anticholinergics: A clinical review
Malaz Boustani, M. (2009) · Clinical Interventions in Aging · doi:10.2147/cia.s5358 · Cited by 479
Postoperative Delirium: A Review of 80 Primary Data-Collection Studies
Dyer, C. B. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430050035004 · Cited by 426
Carrière, I., Fourrier-Reglat, A., Dartigues, J.-F., Rouaud, O., Pasquier, F., Ritchie, K., & Ancelin, M.-L. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.229 · Cited by 374
Kay, G., Crook, T., Rekeda, L., Lima, R., Ebinger, U., Arguinzoniz, M., & Steel, M. (2006) · European Urology · doi:10.1016/j.eururo.2006.03.057 · Cited by 302
Drug Burden Index Score and Functional Decline in Older People
Hilmer, S. N., Mager, D. E., Simonsick, E. M., Ling, S. M., Windham, B. G., Harris, T. B., Shorr, R. I., Bauer, D. C., & Abernethy, D. R. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.02.021 · Cited by 254
Tannenbaum, C., Paquette, A., Hilmer, S., Holroyd-Leduc, J., & Carnahan, R. (2012) · Drugs & Aging · doi:10.1007/bf03262280 · Cited by 241
Han, L., Agostini, J. V., & Allore, H. G. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.02009.x · Cited by 238
Associations Between Drug Burden Index and Falls in Older People in Residential Aged Care
Wilson, N. M., Hilmer, S. N., March, L. M., Cameron, I. D., Lord, S. R., Seibel, M. J., Mason, R. S., Chen, J. S., Cumming, R. G., & Sambrook, P. N. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03386.x · Cited by 211
Long-term anticholinergic use and the aging brain
Cai, X., Campbell, N., Khan, B., Callahan, C., & Boustani, M. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.02.005 · Cited by 202
Self-citationUse of anticholinergics and the risk of cognitive impairment in an African American population
Campbell, N. L., Boustani, M. A., Lane, K. A., Gao, S., Hendrie, H., Khan, B. A., Murrell, J. R., Unverzagt, F. W., Hake, A., Smith-Gamble, V., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e7f2ab · Cited by 194
Self-citationPsychoactive Medications and Risk of Delirium in Hospitalized Cancer Patients
Gaudreau, J.-D., Gagnon, P., Harel, F., Roy, M.-A., & Tremblay, A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.140 · Cited by 193
Cao, Y.-J., Mager, D., Simonsick, E., Hilmer, S., Ling, S., Windham, B., Crentsil, V, Yasar, S., Fried, L., & Abernethy, D. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100303 · Cited by 188
Pasina, L., Djade, C. D., Lucca, U., Nobili, A., Tettamanti, M., Franchi, C., Salerno, F., Corrao, S., Marengoni, A., Iorio, A., et al. (2013) · Drugs & Aging · doi:10.1007/s40266-012-0044-x · Cited by 186
ASSESSMENT OF COGNITIVE FUNCTION OF THE ELDERLY POPULATION: EFFECTS OF DARIFENACIN
LIPTON, R. B., KOLODNER, K., & WESNES, K. (2005) · Journal of Urology · doi:10.1097/01.ju.0000148963.21096.5d · Cited by 179
Drug Burden Index and physical function in older Australian men
Gnjidic, D., Cumming, R. G., Le Couteur, D. G., Handelsman, D. J., Naganathan, V., Abernethy, D. R., & Hilmer, S. N. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03411.x · Cited by 166
Ness, J., Hoth, A., Barnett, M. J., Shorr, R. I., & Kaboli, P. J. (2006) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2006.03.008 · Cited by 158
MabsBase: A Mycobacterium abscessus Genome and Annotation Database
Heydari, H., Wee, W. Y., Lokanathan, N., Hari, R., Yusoff, A. M., Beh, C. Y., Yazdi, A. H., Wong, G. J., Ngeow, Y. F., & Choo, S. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062443 · Cited by 157
Harvey, P. D., Green, M. F., McGurk, S. R., & Meltzer, H. Y. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1342-5 · Cited by 156
The 2012 update to the anticholinergic cognitive burden scale
Campbell, N., Maidment, I., Fox, C., Khan, B., & Boustani, M. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.2013.61.issue-s1 · Cited by 144
Self-citationKersten, H., Molden, E., Tolo, I. K., Skovlund, E., Engedal, K., & Wyller, T. B. (2013) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gls176 · Cited by 131
Mangoni, A. A., Munster, B. C. V., Woodman, R. J., & de Rooij, S. E. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.01.012 · Cited by 106
Lampela, P., Lavikainen, P., Garcia-Horsman, A., Bell, J. S., Huupponen, R., & Hartikainen, S. A. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0063-2 · Cited by 98
The impact of anticholinergic burden in Alzheimer's Dementia-the Laser-AD study
Fox, C., Livingston, G., Maidment, I., Coulton, S., Smithard, D. G., Boustani, M. A., & Katona, C. (2011) · Age and Ageing · doi:10.1093/ageing/afr102 · Cited by 98
Self-citationWesnes, K. A., Edgar, C. J., Tretter, R., & Bolodeoku, J. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903260790 · Cited by 87
Kumpula, E., Bell, J. S., Soini, H., & Pitkälä, K. H. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010368410 · Cited by 86
Tannenbaum, C., Paquette, A., Hilmer, S. N., Holroyd-Leduc, J. M., & Carnahan, R. M. (2012) · Drugs & Aging · doi:10.2165/11633250-000000000-00000 · Cited by 82
Association Between Prescribing of Anticholinergic Medications and Incident Delirium: A Cohort Study
Campbell, N. L., Perkins, A. J., Hui, S. L., Khan, B. A., & Boustani, M. A. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03676.x · Cited by 79
Self-citationKolanowski, A. M., Fick, D. M., Campbell, J., Litaker, M. S., & Boustani, M. A. (2009) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2008.11.005 · Cited by 75
Self-citationCancelli, I., Gigli, G. L., Piani, A., Zanchettin, B., Janes, F., Rinaldi, A., & Valente, M. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31818ce849 · Cited by 74
Kersten, H., Molden, E., Willumsen, T., Engedal, K., & Wyller, T. B. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04411.x · Cited by 63
Anticholinergic Drugs and Their Effects on Delirium and Mortality in the Elderly
Luukkanen, M. J., Uusvaara, J., Laurila, J., Strandberg, T. E., Raivio, M., Tilvis, R. S., & Pitkälä, K. H. (2011) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000322883 · Cited by 63
Cognitive Decline in Older Persons Initiating Anticholinergic Medications
Shah, R. C., Janos, A. L., Kline, J. E., Yu, L., Leurgans, S. E., Wilson, R. S., Wei, P., Bennett, D. A., Heilman, K. M., & Tsao, J. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064111 · Cited by 60
Anticholinergic Drugs in Late Life: Adverse Effects on Cognition but not on Progress to Dementia
Whalley, L. J., Sharma, S., Fox, H. C., Murray, A. D., Staff, R. T., Duthie, A. C., Deary, I. J., & Starr, J. M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-110935 · Cited by 59
Delirium in acute stroke: a preliminary study of the role of anticholinergic medications
Caeiro, L., Ferro, J. M., Claro, M., Coelho, J., Albuquerque, R. I. D. S. S., & Figueira, M. L. (2004) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00897.x · Cited by 59
Uusvaara, J., Pitkälä, K. H., Kautiainen, H., Tilvis, R. S., & Strandberg, T. E. (2010) · Drugs & Aging · doi:10.2165/11585060-000000000-00000 · Cited by 58
Low, L., Anstey, K. J., & Sachdev, P. S. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2157 · Cited by 58
The Association Between Cognition and Histamine‐2 Receptor Antagonists in African Americans
Boustani, M. A., Hall, K. S., Lane, K. A., Aljadhey, H. S., Gao, S., Unverzagt, F. W., Murray, M. D., Ogunniyi, A. O., & Hendrie, H. C. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01270.x · Cited by 57
Self-citationKoyama, A. K., Steinman, M. A., Ensrud, K. E., Hillier, T. A., & Yaffe, K. S. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12093 · Cited by 56
Wiwanitkit, S., & Wiwanitkit, V. (2011) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.91219 · Cited by 55
Effects of Drug Burden Index on Cognitive Function in Older Men
Gnjidic, D., Couteur, D. G. L., Naganathan, V., Cumming, R. G., Creasey, H. M., Waite, L. M., Sharma, A. K., Blyth, F., & Hilmer, S. N. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182487825 · Cited by 53
Barber, S. E., Clegg, A. P., & Young, J. B. (2012) · Age and Ageing · doi:10.1093/ageing/afr138 · Cited by 52
Cardiovascular and respiratory hospitalizations and mortality among users of tiotropium in Denmark
de Luise, C., Lanes, S., Jacobsen, J. B., Pedersen, L., & Sørensen, H. T. (2007) · European Journal of Epidemiology · doi:10.1007/s10654-007-9106-5 · Cited by 50
Yeh, Y.-C., Liu, C., Peng, L., Lin, M.-H., & Chen, L. (2012) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12000 · Cited by 47
Wilson, N. M., Hilmer, S. N., MARCH, L. M., Chen, J. S., Gnjidic, D., Mason, R. S., Cameron, I. D., & Sambrook, P. N. (2012) · Drugs & Aging · doi:10.2165/11598570-000000000-00000 · Cited by 44
Geller, E. J., Crane, A. K., Wells, E. C., Robinson, B., Jannelli, M. L., Khandelwal, C. M., Connolly, A. M., Parnell, B. A., Matthews, C. A., Dumond, J. B., et al. (2012) · Clinical Drug Investigation · doi:10.1007/bf03261923 · Cited by 36
Uusvaara, J., Pitkälä, K. H., Kautiainen, H., Tilvis, R. S., & Strandberg, T. E. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0055-2 · Cited by 31
Cognitive impact of anticholinergic medication in MS: Adding insult to injury?
Cruce, R., Vosoughi, R., & Freedman, M. S. (2012) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2012.05.002 · Cited by 27
Use of drugs with anticholinegic effects and cognitive impairment in community-living older persons
Merchant, R. A., Li, B., Yap, K. B., & Ng, T. P. (2008) · Age and Ageing · doi:10.1093/ageing/afn240 · Cited by 21
Agar, M. R., To, T. H. M., Plummer, J., Abernethy, A. P., & Currow, D. C. (2010) · Journal of Palliative Medicine · doi:10.1089/jpm.2009.0365 · Cited by 12
Drag, L. L., Wright, S. L., & Bieliauskas, L. A. (2010) · Journal of Applied Gerontology · doi:10.1177/0733464810384592 · Cited by 12
O2‐01–01: The Mayo Clinic study of aging: Incidence of mild cognitive impairment
Petersen, R. C., Roberts, R. O., Knopman, D. S., Geda, Y. E., Pankratz, V. S., Boeve, B. F., & Rocca, W. A. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.304 · Cited by 2
Cited by
By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13702 · Cited by 2,609
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
Hampel, H., Mesulam, M.-M., Cuello, A. C., Farlow, M. R., Giacobini, E., Grossberg, G. T., Khachaturian, A. S., Vergallo, A., Cavedo, E., Snyder, P. J., et al. (2018) · Brain · doi:10.1093/brain/awy132 · Cited by 1,918
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study
Coupland, C. A. C., Hill, T., Dening, T., Morriss, R., Moore, M., & Hippisley-Cox, J. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.0677 · Cited by 637
Ruxton, K., Woodman, R. J., & Mangoni, A. A. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12617 · Cited by 360
Biomarkers of postoperative delirium and cognitive dysfunction
Androsova, G., Krause, R., Winterer, G., & Schneider, R. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00112 · Cited by 257
Metadata
- Authors
- Fox, C., Smith, T., Maidment, I., Chan, W.-Y., Bua, N., Myint, P. K., Boustani, M., Kwok, C. S., Glover, M., Koopmans, I., & Campbell, N.
- Venue
- Age and Ageing
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-07-19
- Volume
- 43
- Issue
- 5
- Pages
- 604-615
- ISSN
- 0002-0729 (ISSN-L)
- 1468-2834
- OpenAlex
- W2162173660
- Cited by
- 336
- References
- 60
- FWCI
- 1.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.